Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Top Research Reports for Berkshire Hathaway, Intel & American Tower – June 29, 2020

researchsnappy by researchsnappy
June 29, 2020
in Investment Research
0
Top Research Reports for Berkshire Hathaway, Intel & American Tower – June 29, 2020
400
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter

Monday, June 29, 2020

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Intel (INTC) and American Tower (AMT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Berkshire Hathaway’s shares have outperformed the Zacks Insurance – Property and Casualty industry over the past year (-18.3% vs. -19.4%). The Zacks analyst believes that Berkshire’s inorganic growth story remains impressive with strategic acquisitions.

A strong cash position supports earnings-accretive bolt-on buyouts and indicates its financial flexibility. Continued insurance business growth fuels increase in float, drive earnings and generates maximum return on equity. The non-insurance businesses are delivering improved results with increased revenues over the past few years.

A sturdy capital level provides further impetus. However, exposure to catastrophe loss induces earnings volatility and also affects the property and casualty underwriting results. Also, huge capital expenditure remains a headwind. 

(You can read the full research report on Berkshire Hathaway here >>>)

Shares of Intel have lost -3.6% over the past six months against the Zacks General Semiconductor industry’s rise of +13%. The Zacks analyst believes that Intel is benefiting from momentum across both PC-centric and Data-centric domains.

Robust mix of high-performance second-generation Xeon Scalable processors and solid demand from Cloud service providers are expected to drive near-term growth. Moreover, the company is making advancements in the IoT space, courtesy of product introductions and tie ups. Additionally, Intel is witnessing strong momentum for its first 10-nanometer (nm) mobile CPU.

Notably, the company has not provided 2020 guidance citing coronavirus crisis-induced business uncertainty. Also, declining PC total addressable market, higher expenses pertaining to 10-nm ramp up and constrained supply amid coronavirus outbreak remain concerns.

(You can read the full research report on Intel here >>>)

American Tower’s shares have gained +6.9% over the past three months against the Zacks REIT and Equity Trust industry’s rise of +7.4%. The Zacks analyst believes that the increasing demand for the company’s telecom towers will likely continue to support American Tower’s leasing activities and drive organic tenant-billing growth over the long term.

Moreover, the company is expanding its international presence, opening growth avenues. American Tower also remains committed to increase shareholder value through dividend hikes.

However, amid the coronavirus-led volatility in foreign currency exchange rates, the company lowered the 2020 outlook. Additionally, consolidation trends in the telecom sector is concerning. Furthermore, stiff competition in the tower industry is a headwind.  

(You can read the full research report on American Tower here >>>)

Other noteworthy reports we are featuring today include NextEra Energy (NEE), Bayer (BAYRY) and Booking Holdings (BKNG).

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Previous Post

COVID19 Impact Analysis: Halal Cosmetics and Personal Care Products Market Consumer research, CAGR Status, Forecast Report Covering Major Key Points Like – Business outlook, Key players, Market Revenue Size & Share, Industry Analysis

Next Post

Television Viewing Time and Cardiovascular Disease Risk in Physically Active Adults

Next Post
Television Viewing Time and Cardiovascular Disease Risk in Physically Active Adults

Television Viewing Time and Cardiovascular Disease Risk in Physically Active Adults

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com